Lorcaserin treatment decreases body weight and improves cardiometabolic risk factors of obese adults: A 6-month-long, randomized, placebo-controlled, double-blind clinical trial.

類似資料

• Branched-Chain Amino Acids in relation to Food Preferences and Insulin Resistance in Obese Subjects Consuming Walnuts: A Cross-Over, Randomized, Double-Blind, Placebo-Controlled inpatient physiology study.
  著者:: Tuccinardi, Dario, 等
  出版事項: (2021)
• Walnut consumption increases activation of the insula to highly desirable food cues: A randomized, double-blind, placebo-controlled, cross-over fMRI study
  著者:: Farr, Olivia M., 等
  出版事項: (2017)
• Research advances in metabolism 2016
  著者:: Perakakis, Nikolaos, 等
  出版事項: (2016)
• Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial
  著者:: Farr, Olivia M., 等
  出版事項: (2016)
• Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology study
  著者:: Tuccinardi, Dario, 等
  出版事項: (2019)